Registry for patients with cardiac amyloidosis at University Hospital Leipzig
Cardiac Amyloidosis Registry of University Hospital Leipzig
This study is collecting information from patients with cardiac amyloidosis at University Hospital Leipzig to better understand the disease and improve treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | University of Leipzig Academic / other |
| Locations | 1 site (Leipzig, Saxony) |
| Trial ID | NCT06129656 on ClinicalTrials.gov |
What this trial studies
This registry collects detailed information on patients diagnosed with cardiac amyloidosis at University Hospital Leipzig. It aims to gather data on clinical events, symptoms, imaging results, biomarkers, comorbidities, and treatment outcomes from routine patient management, which are often not captured in randomized clinical trials. By reflecting real-world clinical practice, the registry seeks to enhance understanding of the disease's epidemiology, diagnostic methods, and long-term outcomes. The data collected will also help validate findings from clinical trials and improve treatment implementation and patient monitoring.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals with a confirmed diagnosis of cardiac amyloidosis.
Not a fit: Patients who refuse to participate in the registry will not benefit from the data collection and insights generated.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights that improve the management and treatment of cardiac amyloidosis, leading to better patient outcomes.
How similar studies have performed: Other clinical registries have successfully provided important real-world data that complements findings from randomized trials, making this approach well-supported.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed cardiac amyloidosis according to current standards Exclusion Criteria: * refusal to participate
Where this trial is running
Leipzig, Saxony
- University Hospital Leipzig — Leipzig, Saxony, Germany (Recruiting)
Study contacts
- Principal investigator: Daniel Lavall, MD — University of Leipzig
- Study coordinator: Daniel Lavall, MD
- Email: daniel.lavall@medizin.uni-leipzig.de
- Phone: +493419712650
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.